Related Experiment Video

Updated: Aug 26, 2026

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy

Thierry Magnaldo1

  • 1Laboratory of Genetic Instability and Cancer, CNRS UPR 2169, Institut Gustave Roussy, 39 rue Camille Desmoulin, 94805 Villejuif Cedex 05, France. magnaldo@igr.fr

Expert Opinion on Biological Therapy
|March 5, 2004
PubMed

Insights

Xeroderma pigmentosum (XP) is a rare genetic disorder causing extreme sun sensitivity and high skin cancer risk due to DNA repair defects. Gene therapy using corrected skin cells offers a promising new treatment approach for XP patients.

Area of Science:

  • Genetics
  • Dermatology
  • Molecular Biology

Background:

  • Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder.
  • XP patients exhibit extreme photosensitivity and a high risk of skin tumors.
  • The disease stems from deficient nucleotide excision repair (NER), leading to UV-induced mutations and cancer predisposition.

Purpose of the Study:

  • To explore the potential of cutaneous gene therapy for Xeroderma pigmentosum.
  • To demonstrate the feasibility of reconstructing genetically corrected XP skin in vitro.

Main Methods:

  • Reconstruction of XP skin in vitro using XP keratinocytes and fibroblasts.
  • Retrovirus-mediated transfer of the wild-type XP gene into XP keratinocytes.
  • Phenotypic reversion assessment of genetically corrected XP keratinocytes.

Main Results:

  • Successful in vitro reconstruction of XP skin from patient-derived cells.
  • Demonstrated full reversion of the XP keratinocyte phenotype after gene transfer.
  • Established the efficacy of retrovirus-mediated gene therapy in correcting XP cells.

Conclusions:

  • In vitro reconstruction of genetically corrected XP skin is achievable.
  • Cutaneous gene therapy holds significant promise for treating Xeroderma pigmentosum.
  • This approach offers new hope for managing XP and reducing cancer risk.

More Related Videos

Direct Reprogramming of Mouse Fibroblasts into Melanocytes09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy09:46

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...